SavedAdd your journal

Journals / Journal of Medical Topics and Updates / 2022 / Cilt: 1 Sayı: 3

Effects of iloprost infusion on the eyes due to ovarian ischemia reperfusion ınjury: an experimental study in rats

Over iskemi reperfüzyon hasarına karşı verilen iloprost infüzyonunun göz üzerine etkileri: ratlarda deneysel çalışma

Fadime Tosun(ADIYAMAN ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0003-4660-5497
Ebru Annaç(ADIYAMAN ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0001-9726-5846
Mevlüt Doğukan(ADIYAMAN ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-4890-758X
Mehmet Duran(ADIYAMAN ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0001-7568-3537
Öznur Uludag(ADIYAMAN ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-6017-5836
Pages
152–159
Publication Date
2022-12-23
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Background: In this study, it is aimed to investigate the effect of iloprost treatment on the eye, which is a prostaglandin analogue, given to rats after the ovarian ischemia-reperfusion model and to contribute to the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: In this study, it is aimed to investigate the effect of iloprost treatment on the eye, which is a prostaglandin analogue, given to rats after the ovarian ischemia-reperfusion model and to contribute to the literature.
📊
Key Findings & Data:Background: In this study, it is aimed to investigate the effect of iloprost treatment on the eye, which is a prostaglandin analogue, given to rats after the ovarian ischemia-reperfusion model and to contribute to the literature.
💡
Conclusion & Impact:Background: In this study, it is aimed to investigate the effect of iloprost treatment on the eye, which is a prostaglandin analogue, given to rats after the ovarian ischemia-reperfusion model and to contribute to the literature.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Sıçan · İloprost · İskemi/Reperfüzyon Modeli

Abstract

Background: In this study, it is aimed to investigate the effect of iloprost treatment on the eye, which is a prostaglandin analogue, given to rats after the ovarian ischemia-reperfusion model and to contribute to the literature.

Özet

Amaç: Bu çalışmada, ratlara ovarial iskemi reperfüzyon (İ/R) modeli sonrası verilen prostoglandin analoğu olan iloprost tedavisinin uzak organ olarak göz üzerine etkilerini araştırmak ve literatüre katkıda bulunmak amaçlanmıştır.

🔖

Cite This Article

Tosun, F., Annaç, E., Doğukan, M., Duran, M., Uludag, Ö. (2022). Effects of iloprost infusion on the eyes due to ovarian ischemia reperfusion ınjury: an experimental study in rats. Journal of Medical Topics and Updates, Cilt: 1 Sayı: 3, 152–159. https://ajindex.com/articles/1618901

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (30)

  1. Azarkish F., Armin F., Parvar A.A.A. & Dehghani A. (2021). The influence of renal ischemia-reperfusion injury on remote organs: The histological brain changes in male and female rats. Brain Circ, 7(3), 194-200. doi: 10.4103/bc.bc3_21.
  2. Banda M.A., Lefer D.J. & Granger D.N. (1997). Post ischemic endothelium-dependent vascular reactivity is preserved in adhesion molecule deficient mice. Am J Physiol, 273:2721-5. doi: 10.1152/ajpheart.1997.273.6.H2721
  3. Birukova A.A., Wu T., Tian Y., Meliton A., Sarich N., TianX.,Leff A. & Birukov K.G. (2013). Iloprost improves endothelia lbarrier function in lipopolysaccharide-induced lung injury. Eur Respir J, 41(1), 165-176. doi: 10.1183/09031936.00148311.
  4. Canacankatan N., Sucu N., Aytacoglu B., Gul O.E., Gorur A., Korkmaz B., Sahan-Firat S., Antmen E.S., Tamer L., Ayaz L., Vezir O., Kanik A. & Tunctan B. (2012). Affirmative effects of iloprost on apoptosis during ischemia-reperfusion injury in kidney as a distant organ. Ren Fail, 34(1), 111-118. doi: 10.3109/0886022X.2011.633446.
  5. Carden D.L. & Granger D.N. (2000). Pathophysiology of ischaemia-reperfusion injury. J Pathol, 190(3), 255-66. doi: 10.1002/(SICI)10969896(200002)190:3 3.0.CO;2-6.
  6. Ekim H., Erdoğan H.B., Kutay V., Başel H., Özen S., Hazar A, Akbayrak H. & Özbek H. (2005). Effect of ıschemia/reperfusion ınjury to the lungs caused by cross camping of the abdominal aorta. Van Tıp Dergisi, 12 (3),175-178.
  7. Eltzschig H.K. & Collard C.D. (2004). Vascular ischaemia and reperfusion injury. Br Med Bull, 70, 71-86. doi:10.1093/bmb/ldh025
  8. Erer D., Özer A., Demirtaş H., Gönül İ., Kara H., Arpacı H., Comu F.M., Oktar G.L., Arslan M. & Küçük A. (2016). Effects of alprostadil and iloprost on renal, lung, and skeletal muscle injury following hindlimb ischemia-reperfusion injury in rats. Drug Des Devel Ther, 19(10), 2651-2658. doi: 10.2147/DDDT.S110529.
  9. Erre G.L. & Passiu G. (2009). Antioxidant effect of Iloprost: current knowledge and therapeutic implications for systemic sclerosis. Reumatismo, 61(2), 90-97. doi: 10.4081/reumatismo.2009.90.
  10. Fileta J.B., Huang W., Kwon G.P., Filippopoulos T., Ben Y., Dobberfuhl A. & Grosskreutz C.L. (2008). Efficient estimation of retinal ganglion cell number: a stereological approach. Journal of neuroscience methods, 170(1), 1-8.
  11. Holger K., Eltzschig H.K. & Eckle T. (2011). Ischemia and reperfusion—from mechanism to translation. NatMed, 17(11), 1391-1401. doi: 10.1038/nm.2507.
  12. Huang C., Hong M.K. & Ding D.C. (2017). A review of ovary torsion. CiJiYiXueZaZhi, 29(3), 143-147. doi: 10.4103/tcmj.tcmj_55_17
  13. Huang S.S., Wei F.C. & Hung L.M. (2006).Ischemic preconditioning attenuates postischemic leukocyte – endothelial cell interactions role of nitricoxide and protein kinase C. Circ J, 70:1070-1075.
  14. Iriz E., Iriz A., Take G., Ozgul H., Oktar L., Demirtas H., Helvacıoğlu F. & Arslan M. (2015). Iloprostand vitamin C attenuates acute myocardial injury induced by suprarenal aortic ischemia-reperfusion in rabbits. Bratisl Lek Listy, 116(10), 627-631. doi: 10.4149/bll_2015_121.
  15. Karaman S., Ozkan B., Yazir Y., Yardimoglu M., Gok M., Kara O., Vural C., Rencber S., Salih K. & Emek S.K. (2016). Comparison of hyperbaric oxygen versus iloprost treatment in an experimental rat central retinal artery occlusion model. Graefes Arch Clin Exp Ophthalmol, 254(11), 2209-2215. doi: 10.1007/s00417-016-3444-5.
  16. Kart C., Aran T., Guven S., Karahan S.C. & Yulug E. (2011). Acute increase in plasma D-dimerlevel in ovarian torsion: an experimental study. Hum Reprod, 26(3), 564-568. doi: 10.1093/humrep/deq378.
  17. McNamara D.B., Champion H.C. & Kadowitz PJ, (1998). Nonoperative management of lower extremity arterial disease. Part I. Pharmocologic management of peripheral vascular disease. Surg Clin North Am, 78, 447-456.
  18. Nahar, N., Mohamed, S., Mustapha, N.M., Lau, S., Ishak, N.I.M. & Umran, N.S. (2021). Metformin attenuated histopathological ocular deteriorations in a streptozotocin-induced hyperglycemicrat model. Naunyn-Schmiedeberg'sArchives of Pharmacology, 394(3), 457-467.
  19. Özat M., Gungor T., Barun S., Demirogullari B., Sokmensuer L.K., Gulbahar O., Gursoy D & Muftuoglu S. (2009). The effects of iloprost, a prostacyclin analo-gue, in experimental ischaemia/ reperfusion injury in rat ovaries. Experimental and Toxicologic Pathology, 61(5), 519-527.doi: 10.1016/j.etp.2009.06.007.
  20. Özdemir G. & İnanc F. (2005). Zinc may protect remoteocular injury caused by intestinal ischemia reperfusion in rats. Tohoku J ExpMed, 206(3), 247-251. doi: 10.1620/tjem.206.247.
  21. Rowlands T.E., Gough M.J. & Homer-Vanniasinkam S. (1999). Do prostaglandins have a salutary role in skeletal muscle ischaemia-reperfusion injury? Eur J Vasc Endovasc Surg, 18(5), 439-444. doi: 10.1053/ejvs.1999.0929.
  22. Uludağ Ö. (2019). History and Importance of Ethical Rules in Animal Experiment Studies. Adıyaman Üniversitesi Sağlık Bilimleri Derg. 5(1), 1401–1413.
  23. Thomson I.A., Egginton S., Slimms M.H. & Hudlicka O. (1996). Effect of muscle ischemia and iloprost during femoro distal reconstruction on capillary endothelial swelling. Int J Microcirc Clin Exp, 16, 284-290.
  24. Wu M.Y. Yiang G.T., Liao W.T., Tsai A.P., Cheng Y.L., Cheng P.W., Li C.Y. & Li C.J. (2018). Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem, 46, 1650–1667. doi: 10.1159/000489241.
  25. Yellon D.M. & Hausenloy D.J. (2007). Myocardial reperfusion injury. N Engl J Med, 357(11), 1121-1135. doi: 10.1056/NEJMra071667
  26. Yılmaz Y. & Tumkaya L. (2019). Effects of hyperbaric oxygen and iloprost on intestina lischemia-reperfusion induced acute lung injury. Ann Surg Treat Res, 96(1), 34-40. doi: 10.4174/astr.2019.96.1.34.
  27. Yu H., Kalogeris T. & Korthuis R. (2019). Reactive species-induced microvascular dysfunction in ischemia/reperfusion. Free Radic Biol Med, 135,182-197. doi: 10.1016/j.freeradbiomed.2019.02.031.
  28. Zhou M., Yu Y., Luo X., Wang J., Lan X., Liu P., Feng Y. & Jian W. (2021). Myocardial Ischemia-Reperfusion Injury: Therapeutics from a Mitochondria-Centric Perspective. Cardiology, 146(6), 781-792. doi: 10.1159/000518879.
  29. Birukova A.A., Wu T., Tian Y., Meliton A., Sarich N., TianX.,Leff A. & Birukov K.G. (2013). Iloprost improves endothelia lbarrier function in lipopolysaccharide-induced lung injury. Eur Respir J, 41(1), 165-176. doi: 10.1183/09031936.00148311.
  30. Yellon D.M. & Hausenloy D.J. (2007). Myocardial reperfusion injury. N Engl J Med, 357(11), 1121-1135. doi: 10.1056/NEJMra071667